LKHClass I
Antisera, Immunoperoxidase, Chlamydia Spp.
21 CFR 866.3120 / Microbiology
LKH is the FDA product code for Antisera, Immunoperoxidase, Chlamydia Spp., a class I device type, regulated under 21 CFR 866.3120. As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and 6 recalls.
Classification record
- Product code
- LKH
- Device name
- Antisera, Immunoperoxidase, Chlamydia Spp.
- Regulation
- 21 CFR 866.3120
- Device class
- Class I
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 8
- Ingested recalls
- 6
Clearances, product code LKH
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1982 | 1 |
| 1983 | 1 |
| 1984 | 1 |
| 1985 | 1 |
| 1989 | 2 |
| 1991 | 2 |
Applicants with the most clearances
Product code LKH| Applicant | Clearances |
|---|---|
| Savyon Diagnostics Ltd. | 2 |
| Bartels Immunodiagnostic Supplies, Inc. | 1 |
| Difco Laboratories, Inc. | 1 |
| Icn Immunobiologicals | 1 |
| Immulok, Inc. | 1 |
| Nicholas H. Maganias | 1 |
| Scott Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code LKH.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
